Khadijeh Dizaji Asl | Oncology | Editorial Board Member

Published on by Health Scientists

Editorial Board Member

Khadijeh Dizaji Asl
Islamic Azad University, Iran

                        Khadijeh Dizaji Asl
Affiliation Islamic Azad University
Country Iran
Scopus ID 57221391321
Documents 21
Citations 207
h-index 8
Subject Area Oncology
Event Health Scientists Awards
ORCID 0000-0003-0920-9583

Khadijeh Dizaji Asl is an oncology-focused researcher affiliated with Islamic Azad University, Iran. Her scholarly activities contribute to the advancement of cancer-related research, clinical understanding, and evidence-based scientific inquiry. Through publications indexed in major academic databases and an established citation record, she has demonstrated sustained engagement with oncology research and interdisciplinary scientific collaboration.[1][2]

Abstract

Khadijeh Dizaji Asl is an oncology researcher affiliated with Islamic Azad University whose scholarly record reflects active participation in cancer-related investigations and biomedical research. Her publications address topics associated with oncology, disease mechanisms, clinical outcomes, and evidence-based healthcare approaches. Indexed academic outputs, citation performance, and an established h-index indicate measurable scientific visibility within her research field. Through collaboration, publication, and dissemination of findings, she contributes to the broader understanding of oncological challenges and supports the development of knowledge that informs future research directions and clinical applications in cancer science.[1][2]

Keywords

Oncology, Cancer Research, Clinical Oncology, Biomedical Science, Tumor Biology, Medical Research, Health Sciences, Evidence-Based Medicine, Cancer Studies, Scientific Publications

Introduction

Khadijeh Dizaji Asl has developed a research profile centered on oncology and related biomedical disciplines. Her scholarly work contributes to the growing body of scientific literature addressing cancer mechanisms, treatment perspectives, and healthcare outcomes. Academic indexing and citation metrics demonstrate continued engagement with internationally visible research activities.[1]

Research Profile

Affiliated with Islamic Azad University, Khadijeh Dizaji Asl has authored publications indexed in Scopus and other academic platforms. Her research interests primarily involve oncology-related investigations, scientific collaboration, and dissemination of evidence supporting advancements in cancer research and healthcare knowledge.[1][2]

Research Contributions

Her scholarly contributions include participation in studies that enhance understanding of oncological processes and clinical implications. Through peer-reviewed publications, she has supported scientific discussion surrounding cancer research, contributing data and analyses that strengthen evidence-based approaches within the field.[1][3]

Publications

The publication portfolio of Khadijeh Dizaji Asl includes twenty-one indexed documents with measurable citation performance. Her research outputs appear within recognized scholarly channels and contribute to the dissemination of oncology-focused findings relevant to researchers, clinicians, and healthcare stakeholders.[1]

Research Impact

With more than two hundred citations and an h-index of eight, her work demonstrates scholarly recognition within the scientific community. These indicators suggest that published findings have informed subsequent studies and contributed to ongoing academic discourse in oncology research.[1][2]

Award Suitability

Based on her documented research productivity, citation record, and commitment to oncology scholarship, Khadijeh Dizaji Asl demonstrates qualifications aligned with recognition programs that value scientific contribution, academic engagement, and advancement of health-related research within the international research community.[4]

Conclusion

Khadijeh Dizaji Asl has established a visible academic presence through oncology-focused research, indexed publications, and scholarly citations. Her contributions support scientific understanding of cancer-related topics and reflect ongoing participation in research activities that advance evidence-based knowledge and healthcare scholarship.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Khadijeh Dizaji Asl, Author ID 57221391321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57221391321
  2. ORCID. (n.d.). Khadijeh Dizaji Asl: ORCID record 0000-0003-0920-9583.https://orcid.org/0000-0003-0920-9583
  3. Google Scholar. (n.d.). Scholar profile of Khadijeh Dizaji Asl.https://scholar.google.com/citations?user=fyQaW6YAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Khadijeh Dizaji Asl researcher profile.https://www.researchgate.net/profile/Khadijeh-Dizaji-Asl

Dimitrios Bouklas | Oncology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Dimitrios Bouklas
General Hospital of Athens “G. Gennimatas”
          Dimitrios Bouklas
Affiliation General Hospital of Athens “G. Gennimatas”
Country Greece
Scopus ID 57372362800
Documents 5
Citations 2
h-index 1
Subject Area Oncology
Event Health Scientists Awards
ORCID 0000-0002-5858-0357

Dimitrios Bouklas is affiliated with the General Hospital of Athens “G. Gennimatas” in Greece and contributes to oncology-related clinical and scientific investigations. His scholarly profile demonstrates engagement in cancer research and healthcare studies, supported by indexed publications and citation records available through international academic databases.[1][2]

Abstract

Dimitrios Bouklas has developed a research profile focused on oncology and clinical healthcare studies within a hospital-based environment. His published work contributes to understanding cancer-related conditions, patient management approaches, and evidence-based medical practice. Indexed publications demonstrate participation in multidisciplinary scientific investigations and collaboration with healthcare professionals. Through dissemination of peer-reviewed research, his work supports ongoing efforts to improve clinical knowledge and patient outcomes. The available scholarly metrics, including indexed documents, citations, and author identifiers, indicate active engagement in scientific communication and contribution to contemporary oncology literature and healthcare research initiatives.[1][2]

Keywords

Oncology, Cancer Research, Clinical Oncology, Healthcare Research, Medical Science, Hospital-Based Research, Cancer Care, Clinical Studies, Patient Outcomes, Scientific Publications

Introduction

The advancement of oncology relies on continuous clinical investigation and evidence-based practice. Dimitrios Bouklas contributes to this field through participation in research activities associated with cancer care, clinical assessment, and healthcare improvement, supporting scientific understanding and the translation of research findings into medical practice.[1]

Research Profile

His academic profile is represented through indexed publications in oncology and related healthcare disciplines. Affiliated with a major healthcare institution in Greece, he participates in scientific studies addressing clinical challenges, patient care considerations, and disease-related investigations within contemporary medical research environments.[1][2]

Research Contributions

Dimitrios Bouklas has contributed to peer-reviewed investigations involving oncology-focused clinical research. His work supports scientific discussion on disease management, healthcare outcomes, and multidisciplinary medical collaboration. These contributions enhance the evidence base available to clinicians and researchers working in cancer-related healthcare settings.[1]

Publications

The researcher’s publication record includes indexed scientific articles documented within Scopus and other scholarly platforms. These works reflect involvement in oncology and clinical medicine research, contributing to the dissemination of healthcare knowledge through peer-reviewed academic literature and professional scientific communication.[1][3]

Research Impact

Research impact is reflected through citation activity, indexed publications, and professional visibility across scholarly databases. Although at an early citation stage, the documented work contributes to oncology literature and supports ongoing academic engagement within clinical and healthcare research communities.[1][4]

Award Suitability

Dimitrios Bouklas demonstrates qualifications aligned with the objectives of the Innovative Research Award through documented scholarly activity, oncology-focused investigations, and participation in scientific publication. His commitment to advancing clinical knowledge and supporting evidence-based healthcare makes him a relevant candidate for academic recognition.[1][2]

Conclusion

The academic profile of Dimitrios Bouklas reflects meaningful engagement in oncology research and scientific communication. Through publications, institutional affiliation, and participation in healthcare studies, he contributes to the advancement of medical knowledge and demonstrates characteristics consistent with emerging research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Dimitrios Bouklas, Author ID 57372362800. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57372362800

  2. ORCID. (n.d.). Dimitrios Bouklas – ORCID Record.

    https://orcid.org/0000-0002-5858-0357

  3. ResearchGate. (n.d.). Dimitrios Bouklas Research Profile and Publications.

    https://www.researchgate.net/profile/Dimitrios-Bouklas

  4. Google Scholar. (n.d.). Dimitrios Bouklas Citation Profile.

    https://scholar.google.com/citations?user=h6mhYUIAAAAJ&hl=en&oi=ao

Pao-Chu Chen | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Pao-Chu Chen — Hualien Tzu Chi Hospital
Academic Profile
Researcher Pao-Chu Chen
Affiliation Hualien Tzu Chi Hospital
Country Taiwan
Scopus ID 37081956700
Documents 30
Citations 307
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ResearchGate Profile Link

Pao-Chu Chen is affiliated with Hualien Tzu Chi Hospital in Taiwan and has contributed to clinical medicine research through indexed scientific publications and interdisciplinary healthcare studies. The academic profile demonstrates measurable citation impact and participation in scientific communication systems associated with international biomedical research visibility.[1]

Abstract

This article summarizes the academic profile and scientific contributions of Pao-Chu Chen from Hualien Tzu Chi Hospital, Taiwan. The researcher has contributed to clinical medicine through indexed publications, interdisciplinary healthcare research, and scholarly communication activities. Citation indicators and publication metrics demonstrate measurable academic visibility within international biomedical databases. The profile reflects participation in scientific dissemination, healthcare investigation, and research collaboration associated with clinical medicine and public health advancement. Recognition within the Health Scientists Awards framework highlights scholarly engagement, publication quality, and contribution to evidence-based healthcare research within contemporary academic and clinical environments.[1]

Keywords

  • Clinical Medicine
  • Biomedical Research
  • Health Sciences
  • Healthcare Studies
  • Scopus Author Profile
  • Health Scientists Awards

Introduction

Clinical medicine research contributes to evidence-based healthcare practices, disease management, and interdisciplinary scientific advancement. Researchers engaged in this field support medical knowledge dissemination through peer-reviewed publications, healthcare investigations, and collaborative scientific communication systems within international academic and clinical research environments.[2]

Research Profile

Pao-Chu Chen maintains an academic profile associated with Hualien Tzu Chi Hospital and indexed scientific publications in clinical medicine. Bibliometric indicators demonstrate research visibility through citation activity, scholarly dissemination, and participation in international scientific databases supporting healthcare-related academic communication.[1]

Research Contributions

The researcher has contributed to clinical medicine through healthcare investigations, biomedical publication activities, and scientific collaboration. Research dissemination through indexed journals supports the exchange of validated medical knowledge and strengthens interdisciplinary communication within international healthcare and biomedical research communities.[3]

Publications

The publication record associated with Pao-Chu Chen includes indexed scientific articles contributing to clinical medicine and healthcare research. Peer-reviewed publications support citation visibility, academic dissemination, and integration into international bibliographic databases used for scholarly communication and biomedical knowledge distribution.[1]

Research Impact

Research impact is reflected through publication indexing, citation metrics, and participation in scientific communication systems. The researcher’s academic profile demonstrates measurable scholarly visibility and contribution to healthcare-related scientific literature within internationally recognized biomedical and clinical research databases.[1]

Award Suitability

The academic profile of Pao-Chu Chen aligns with recognition criteria associated with scientific publication activity, citation visibility, and healthcare research contribution. Participation in indexed scholarly communication systems demonstrates engagement with biomedical dissemination practices supporting international academic and clinical research advancement.[4]

Conclusion

Pao-Chu Chen demonstrates sustained involvement in clinical medicine research through indexed publications, citation visibility, and scientific dissemination activities. The academic profile reflects interdisciplinary healthcare engagement and contribution to biomedical scholarship within international research environments supporting evidence-based healthcare communication and scientific advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Pao-Chu Chen, Author ID 37081956700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37081956700
  2. Subramani, K., Su, C.-C., Wang, J.-H., Huang, H.-S., Hsu, C.-S., Chen, P.-C., & Chu, T.-Y. (2025). Tubal ligation exacerbates ovulation-driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin. The Journal of Pathology.
    https://pathsocjournals.onlinelibrary.wiley.com/doi/abs/10.1002/path.70064
  3. Chu, T., Chen, Pao-Chu, Khine, A. A., et al. (2025). Ovulation releases G-CSF to induce peritoneal neutrophil influx and netosis, facilitating peritoneal seeding of high-grade serous carcinoma. Neoplasia.
    https://pubmed.ncbi.nlm.nih.gov/41046768/
  4. Health Scientists Awards. (n.d.). Academic recognition and scientific excellence framework.
    Health Scientists Awards

Eleftherios Papaeleftheriou | Clinical Medicine | Top Clinical Research Award

Published on by Health Scientists

Top Clinical Research Award

Eleftherios Papaeleftheriou
St. Mary’s Hospital Mülheim an der Ruhr, Germany

Eleftherios Papaeleftheriou
Researcher Eleftherios Papaeleftheriou
Affiliation St. Mary’s Hospital Mülheim an der Ruhr
Country Germany
Scopus ID 53881624200
Documents 2
Citations 7
h-index 1
Subject Area Clinical Medicine
Event Health Scientists Awards
Scopus Profile View Profile

The Top Clinical Research Award recognizes the scholarly and clinical research contributions of Eleftherios Papaeleftheriou associated with St. Mary’s Hospital Mülheim an der Ruhr in Germany. The recognition reflects engagement in Clinical Medicine research, scientific communication, and internationally indexed academic dissemination through peer-reviewed publication activity.[1] The award framework acknowledges measurable scholarly participation within clinical and healthcare-oriented research environments supported by internationally recognized academic indexing systems.[2] Additional scholarly infrastructure and citation indexing resources further support international accessibility and publication discoverability.[3]

Abstract

Eleftherios Papaeleftheriou is associated with scholarly activities in Clinical Medicine and healthcare-related research dissemination. Indexed academic contributions reflect participation in peer-reviewed publication systems, citation-based evaluation, and scientific communication relevant to clinical and medical investigation.[1] Research visibility supported through international academic platforms contributes to broader engagement within healthcare and clinical research communities.[3]

Keywords

  • Clinical Medicine
  • Medical Research
  • Scientific Dissemination
  • Clinical Investigation
  • Healthcare Innovation
  • Academic Publications
  • Indexed Research

Introduction

Academic recognition programs in healthcare and biomedical sciences acknowledge scholarly contribution and international scientific communication. The Health Scientists Awards Top Clinical Research Award recognizes researchers engaged in clinical investigation and indexed dissemination.[2] Eleftherios Papaeleftheriou demonstrates scholarly involvement in Clinical Medicine through indexed publications and citation-based evaluation, contributing to academic visibility and engagement within broader medical research communities.[1]

Research Profile

Eleftherios Papaeleftheriou is affiliated with St. Mary’s Hospital Mülheim an der Ruhr in Germany and maintains a scholarly profile indexed through Scopus academic databases.[1] The research profile includes two indexed documents, seven citations, and an h-index value of one, demonstrating participation in scholarly communication and clinical research dissemination. The researcher’s academic activities are associated with Clinical Medicine and healthcare-oriented scientific inquiry, supporting knowledge dissemination within peer-reviewed and internationally accessible research environments.[3]

Research Contributions

The scholarly activities associated with Eleftherios Papaeleftheriou contribute to medical and healthcare-oriented academic communication through indexed publication and citation-based dissemination systems.[1]

  • Participation in clinical and healthcare-related academic research.
  • Contribution to peer-reviewed scientific publication systems.
  • Support for internationally indexed research dissemination.
  • Engagement in citation-based scholarly communication activities.

Publications

Indexed publications associated with Eleftherios Papaeleftheriou contribute to academic visibility and accessibility within international scientific databases. Citation metrics and indexed documentation support evaluation of scholarly dissemination and clinical research engagement.[1]

  1. Peer-reviewed publications associated with Clinical Medicine.
  2. Scientific dissemination through internationally indexed academic databases.
  3. Citation-based contribution to healthcare-related scholarly communication.

Research Impact

Research impact within Clinical Medicine is commonly evaluated through publication visibility, citation activity, and participation in internationally recognized scientific dissemination systems. The indexed academic profile associated with Eleftherios Papaeleftheriou reflects measurable scholarly engagement within healthcare-oriented research environments.[1] Recognition through international academic award frameworks may additionally support interdisciplinary networking, collaborative healthcare investigation, and broader scientific communication opportunities.[2]

Award Suitability

The academic and clinical research profile of Eleftherios Papaeleftheriou reflects characteristics associated with scholarly recognition programs, including indexed publication activity, citation-based visibility, and participation in international scientific dissemination systems.[1] The researcher’s engagement within Clinical Medicine contributes to healthcare-related academic communication and supports continued participation within global scientific and medical research initiatives.[3]

Conclusion

Eleftherios Papaeleftheriou demonstrates scholarly participation within Clinical Medicine through indexed publication activity, scientific dissemination, and engagement in internationally accessible healthcare research systems.[1] Citation indicators and publication visibility collectively support recognition within academic and clinical research communities.[3] The Top Clinical Research Award under the Health Scientists Awards framework represents acknowledgment of scholarly contribution, healthcare-oriented scientific engagement, and participation in international research dissemination initiatives.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Eleftherios Papaeleftheriou, Author ID 53881624200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=53881624200
  2. Health Scientists Awards. (n.d.). International academic recognition and healthcare research award framework.

    https://healthscientists.org/
  3. Sowislok, A., Gruber, G., Kaschani, F., Kaiser, M., Papaeleftheriou, E., & Jäger, M. (2025). Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins. PubMed.

    https://pubmed.ncbi.nlm.nih.gov/41003411/

Gauthami Pulivendala | Translational Research | Young Researcher Award

Published on by Health Scientists

Dr. Gauthami Pulivendala | Translational Research | Young Researcher Award

Postdoc Associate | University of Miami | United States

Dr. Gauthami Pulivendala is a researcher at Sylvester Comprehensive Cancer Center, specializing in cancer biology, fibrosis, and molecular signaling pathways. Her work focuses on understanding mechanisms such as the ChREBPα-mediated regulation of hepatic stellate cell activation and its role in liver fibrosis, contributing to advancements in translational oncology. With 11 publications, 318 citations, and an h-index of 9, she demonstrates strong research impact and scientific productivity. Collaborating with an extensive network of co-authors, her research reflects interdisciplinary engagement across cancer biology and metabolic disease domains. Her contributions hold significant societal value by advancing knowledge in fibrosis and tumor microenvironment interactions, supporting the development of targeted therapies, and improving clinical strategies for cancer and liver-related diseases, thereby contributing to global health innovation and patient care outcomes.

Citation Metrics (Scopus)

318
240
160
80
0

Citations

318

Documents

11

h-index

9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications


Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

– Drug Delivery and Translational Research, 2020 | Citations: 62

Lingyu Ding | Oncology | Distinguished Scientist Award

Published on by Health Scientists

Mrs. Lingyu Ding | Oncology | Distinguished Scientist Award

clinical nurse | Jiangsu province hospital | China

Lingyu Ding is a distinguished registered nurse at the Colorectal Surgery Department of The First Affiliated Hospital with Nanjing Medical University, specializing in oncology nursing, perioperative rehabilitation, and cancer-related frailty. She has made significant contributions to the development and validation of frailty assessment models for cancer survivors and has designed and pilot-tested multimodal interventions to manage frailty, demonstrating a strong commitment to improving patient outcomes. Her research has been published extensively in peer-reviewed journals, encompassing systematic reviews, meta-analyses, and observational studies that explore preoperative frailty, sedentary behavior, handgrip strength asymmetry, and postoperative outcomes among older adults with cancer. Lingyu has successfully secured and led a project funded by the National Natural Science Foundation of China, reflecting her leadership and research capabilities, and she actively engages in collaborative projects with multidisciplinary teams. Her work has been recognized with prestigious awards for excellence in professional practice, innovative nursing interventions, and outstanding young talent, underscoring both her academic and clinical impact. Beyond her research, Lingyu contributes to the scholarly community as a peer reviewer for international journals, ensuring the rigor and quality of scientific publications. Her expertise spans both quantitative and qualitative research methodologies, including randomized controlled trials, questionnaire design, phenomenological research, and grounded theory, complemented by proficiency in statistical analysis and academic writing. Through her clinical practice, research, and scholarly activities, Lingyu Ding advances the understanding and management of frailty in cancer patients, bridging the gap between evidence-based research and practical healthcare applications, and making a meaningful impact on patient care, health outcomes, and the broader field of oncology nursing. She has 361 citations from 33 documents with an h-index of 11.

Profile: Scopus 

Featured Publications

1. Willingness, preference, and resistance to frailty intervention for older gastric cancer based on stakeholder perspective: A qualitative study. (2025). BMC Geriatrics. Open access.

2. Clinical characteristics and correlation between preoperative frailty and metabolic syndrome among older patients with gastric cancer. (2025). Chinese General Practice.

3.BMI trajectories, associations with outcomes and predictors in elderly gastric cancer patients undergoing radical gastrectomy: A prospective longitudinal observation study. (2025). Journal of Cancer Survivorship.

Rasha Elsabagh | Oncology | Research Excellence Award

Published on by Health Scientists

Dr. Rasha Elsabagh | Oncology | Research Excellence Award

Researcher | Animal Health Research Institute(AHRI) | Egypt

Rasha H. Elsabagh is a multidisciplinary immunology specialist and cancer stem cell researcher with extensive expertise spanning stem cell biology, immuno-oncology, translational cancer research, and veterinary biomedical sciences. She currently serves as a researcher at the Animal Health Research Institute, where her work integrates advanced immunological diagnostics, molecular biology, and national livestock immunization programs that directly contribute to animal health surveillance and disease control. Her academic training culminated in a doctoral degree in cancer immunology from Cairo University, where her research focused on circulating cancer stem cells and photothermal nanotherapy as predictive and monitoring tools for tumor response. She has conducted advanced international research training at University of California San Francisco, gaining high-level proficiency in flow cytometry, immunofluorescence, and human stem cell analysis, and later expanded her translational oncology experience as a visiting research fellow at the Cancer Institute of Montpellier, working on nanoparticle-mediated RNA delivery to tumor-infiltrating immune cells. Her scientific output includes multiple peer-reviewed publications in high-impact journals and international conference proceedings, with her work receiving sustained scholarly citations and global academic recognition. Her research collaborations span institutions in North America, Europe, and the Middle East, reflecting her active role in international scientific networks in stem cell biology, cancer immunology, and nanomedicine. Beyond laboratory research, she contributes to national capacity building through scientific training, quality assurance in diagnostic immunology, and public health–oriented animal disease control programs. Her work has direct societal impact through improvements in cancer diagnostics, advancement of immunotherapeutic strategies, and strengthening of zoonotic disease surveillance, positioning her as a globally engaged scientist at the intersection of experimental research, translational medicine, and public health. She has 2 citations from 2 documents with an h-index of 1.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Xiao, T., Eze, U. C., Charruyer-Reinwald, A., Weisenberger, T., Khalifa, A., … (2024). Short cell cycle duration is a phenotype of human epidermal stem cells. Stem Cell Research & Therapy, 15(1), 76.

2. Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Ragab, E., … (2021). Quantitative flow cytometry assessment of feline circulatory breast cancer stem cells. Advances in Animal and Veterinary Sciences, 9(12), 2201–2215.

3. Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H. H., Ragab, E., … (2025). Gold nano-rod (AuNR)-mediated plasmonic photothermal therapy in feline mammary carcinoma: Assessing metastatic and nonmetastatic outcomes. Veterinary Oncology, 2(1), 33.

4. Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H., Ragab, E., … (2022). Prevention of in situ recurrence and distant metastasis in feline mammary carcinoma treated with plasmonic photothermal therapy.

 

Niladry Sekhar Ghosh | Oncology | Best Researcher Award

Published on by Health Scientists

Prof. Niladry Sekhar Ghosh | Oncology | Best Researcher Award

Professor | Assam Down Town University, Guwahati | India

Prof. Niladry Sekhar Ghosh is a distinguished researcher and Professor at Assam Down Town University, Guwahati, serving also as Member Secretary of the Board of Studies, with extensive expertise in pharmaceutical sciences, medicinal chemistry, and biomedical research. He earned his B.Pharm. and M.Pharm. degrees from S.C.S College of Pharmacy, R.G.U.H.S Bangalore, graduating with first-class honors, and completed his Ph.D. at Shobhit University in 2020, focusing on the synthesis of bioactive fluoro-benzothiazole derivatives and the biosynthesis of metallic nanoparticles for biological and pharmacological screening. With over 18 years of teaching experience and significant contributions to research, his key areas of interest include drug discovery, medicinal chemistry, nanotechnology-based drug delivery systems, pharmacological evaluation of bioactive compounds, and cancer therapeutics. Prof. Ghosh has authored more than 50 publications in high-impact journals indexed in SCI, Scopus, and ESCI, including studies on cathepsin inhibitors, benzimidazole and indole derivatives as anticancer agents, and green synthesis of nanoparticles. He has been recognized with multiple honors, notably the Young Teacher Awards by SPER in 2016 and 2018, and has secured competitive research grants from SERB-DST, DBT, ICMR, and NCW for innovative projects in pharmaceutical biotechnology and nanomedicine. Additionally, he holds patents for metallic nanoparticle synthesis and biomedical devices. Beyond research, he serves as a resource person, reviewer, and editor for various scientific journals, contributing to the dissemination of knowledge in medicinal chemistry, pharmacology, and nanotechnology. His leadership roles in academic administration and research guidance underscore his commitment to advancing pharmaceutical education and translational research. He has 90 citations from 22 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Dubey, A., Ghosh, N. S., & Singh, R. (2022). Zebrafish as an emerging model: An important testing platform for biomedical science.

2. Dubey, A., Ghosh, N. S., Gupta, A., & Singh, S. (2023). A review on current epidemiology and molecular studies of lumpy skin disease virus—An emerging worldwide threat to domestic animals.

3. Dubey, A., Ghosh, N. S., Agnihotri, N., Kumar, A., Pandey, M., & Nishad, S. (2022). Herbs derived bioactive compounds and their potential for the treatment of neurological disorders.

4. Dubey, A., Ghosh, N. S., Rathor, V. P. S., Patel, S., Patel, B., & Purohit, D. (2022). SARS-CoV-2 infection leads to neurodegenerative or neuropsychiatric diseases.

5. Chandra, D., Yadav, I. K., Jaiswal, D., Ghosh, N., Singh, H. P., Mishra, A., … (Year not specified). Formulation and evaluation of satranidazole microspheres for colon-targeted drug delivery.

Nayeralsadat Fatemi | Oncology | Best Researcher Award

Published on by Health Scientists

Dr. Nayeralsadat Fatemi | Oncology | Best Researcher Award 

Researcher | Research Institute for Gastroenterology and Liver Diseases | Iran

Dr. Nayeralsadat Fatemi is a distinguished Research Scientist at the Research Institute for Gastroenterology and Liver Diseases (RIGLD), Tehran, Iran, with a profound background in genetics and molecular medicine. She obtained her B.Sc. in Genetics from Esfahan University in 2007, followed by an M.Sc. in Genetics from Shahrekord University in 2012, and earned her Ph.D. in Molecular Medicine from Zanjan University of Medical Sciences in 2020. Dr. Fatemi’s research primarily focuses on colorectal cancer, gastrointestinal disorders, reproductive genetics, and the interplay between microbiota and cancer-related molecular pathways. Her work integrates genomics, transcriptomics, and bioinformatics analyses to uncover biomarkers, drug resistance mechanisms, and potential therapeutic targets. She has contributed to over thirty peer-reviewed publications in high-impact journals, including Gut Pathogens, Virulence, Expert Reviews in Molecular Medicine, Digestive Diseases and Sciences, and International Journal of Cancer, with notable studies on Fusobacterium nucleatum in colorectal cancer, microRNA-mediated regulatory networks, and genetic causes of recurrent pregnancy loss. Dr. Fatemi has presented her findings at numerous national and international conferences, earning recognition for excellence in research communication, including Best Poster awards at reproductive medicine congresses. Beyond her research contributions, she serves as an active reviewer and editorial board member for several scientific journals in molecular medicine, cancer biology, and reproductive genetics, reflecting her commitment to advancing scientific rigor and knowledge dissemination in health sciences. Her career exemplifies a dedication to translational research, bridging fundamental molecular discoveries with clinical applications to improve diagnostics, therapeutics, and patient outcomes in gastroenterology and reproductive medicine. She has 218 citations from 31 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Fatemi, N., Tierling, S., Es, H. A., Varkiani, M., Mojarad, E. N., Aghdaei, H. A., … (2022). DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.

2. Fatemi, N., Sanati, M. H., Shamsara, M., Moayer, F., Zavarehei, M. J., Pouya, A., … (2014). TBHP-induced oxidative stress alters microRNAs expression in mouse testis. Journal of Assisted Reproduction and Genetics.

3. Amiri Yekta, A., Dalman, A., Eftekhari-Yazdi, P., Sanati, M. H., Shahverdi, A. H., … (2013). Production of transgenic goats expressing human coagulation factor IX in the mammary glands after nuclear transfer using transfected fetal fibroblast cells.

4. Fatemi, N., Sanati, M. H., Jamali Zavarehei, M., Ayat, H., Esmaeili, V., … (2013). Effect of tertiary‐butyl hydroperoxide (TBHP)‐induced oxidative stress on mice sperm quality and testis histopathology.

5. Rejali, L., Seifollahi Asl, R., Sanjabi, F., Fatemi, N., Asadzadeh Aghdaei, H., … (2023). Principles of molecular utility for CMS classification in colorectal cancer management.

Virginie Guastella | Oncology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Virginie Guastella | Oncology | Best Researcher Award

Associate Professor | University Hospital Clermont-ferrand | France

Dr. Virginie Guastella is a distinguished physician and researcher specializing in palliative care and pain management. She holds a Doctorate in Medicine and an Habilitation à Diriger des Recherches (HDR) focused on opioid analgesics and cancer pain. She currently serves as Head of the Palliative Care Unit at CHU Clermont-Ferrand and as Associate Professor in Palliative Medicine at the University Clermont Auvergne, leading the UIC “Douleur, qualité de vie et maladie grave” within the GRUIC “Douleurs chroniques et thérapeutiques.” Her clinical work emphasizes optimizing pain management, end-of-life care, and therapeutic support for patients with advanced illness, while her research explores critical areas including opioid misuse, the integration of virtual reality and music care in palliative settings, and early detection of chemotherapy-induced neuropathies. She has supervised over 24 medical theses and numerous master-level projects, contributing significantly to clinical education, and is a prolific author with 20 international peer-reviewed publications, multiple national articles, and several book chapters addressing topics from opioid prescribing practices to patient and caregiver experiences in palliative care. Beyond research and clinical responsibilities, she actively participates in national and regional committees, contributes to guideline development, and advocates for palliative medicine education and ethics. Through her combined contributions in research, education, and clinical practice, she has played a pivotal role in advancing patient-centered care, promoting evidence-based practices, and improving the quality of life for patients facing serious illness, establishing herself as a leading figure in palliative care and pain management. She has 485 citations from 41 documents with an h-index of 9.

Profiles: Scopus | ORCID

Featured Publications

1. Lawton, G., Calvel, L., Perceau-Chambard, E., Guastella, V., Economos, G., & Evin, A. (2025). Career trajectories after palliative care training: A national e-survey of medical interns in France.

2. Klaeyle, D., Calvel, L., Perceau-Chambard, E., Guastella, V., Economos, G., & Evin, A. (2025). Teaching palliative medicine in the medical school clerkship in France: A national e-survey.

3. Guastella, V., Lambert, C., Lafforgue, A., Metretin, P., Verstreate, A., Watelet, S., Perceau-Chambard, É., & Lautrette, A. (2024). Withholding or withdrawing life-sustaining treatments in the COVID-19 pandemic.

4. Guastella, V., Delorme, J., Chenaf, C., & Authier, N. (2022). The prevalence of off-label prescribing of transmucosal immediate-release fentanyl in France. Journal of Pain and Symptom Management.

5. Preux, C., Bertin, M., Tarot, A., Authier, N., Pinol, N., Brugnon, D., Pereira, B., & Guastella, V. (2022). Prevalence of opioid use disorder among patients with cancer-related pain: A systematic review.